Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Move comes amid rising regulatory pressures
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
PMDA is regarded among the most stringent regulatory bodies globally
Subscribe To Our Newsletter & Stay Updated